Early Feasibility Study of the Brown Glaucoma Implant in Patients With Severe Visual Impairment or No Light Perceived

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

March 26, 2020

Study Completion Date

September 20, 2021

Conditions
Glaucoma
Interventions
DEVICE

Brown Glaucoma Implant

The Brown Glaucoma Implant (BGI) is an implantable device designed to lower intraocular pressure (IOP) in glaucoma patients by shunting aqueous humor from the anterior chamber of the eye to the surface of the eye. Because there are no physiologic sources of outflow resistance, the device can be engineered to target an IOP that is low enough to halt the progression to blindness in a patient suffering from glaucoma.

Trial Locations (3)

45405

iWorks Laser and Vision Center, Dayton

55431

Minnesota Eye Consultants, Bloomington

75231

Glaucoma Associates of Texas, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MicroOptx

INDUSTRY

NCT03469297 - Early Feasibility Study of the Brown Glaucoma Implant in Patients With Severe Visual Impairment or No Light Perceived | Biotech Hunter | Biotech Hunter